K-12

N/A

Report date: 2023/08/02 14:39:16

Base Information

Drug NameK-12
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes SimplexCytomegalovirus InfectionsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHerpes SimplexCytomegalovirus InfectionsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A